Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma

American Journal of Rhinology and Allergy

Volumn 25, Issue 2, 2011, Pages 75-81

  Kim, Sun Gui ^a   Lee, O Young ^a   Choi, Jin Woong ^a   Park, Yong Ho ^a   Kim, Yong Min ^a   Yeo, Min Kyung ^a   Kim, Jin Man ^a   Rha, Ki Sang ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE; PROTEIN P16; PROTEIN P21; PROTEIN P53; PROTEIN P63;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHILD; CONTROLLED STUDY; DYSPLASIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVERTED PAPILLOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NOSE POLYP; PROTEIN EXPRESSION; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NASAL POLYPS; NEOPLASM STAGING; NOSE NEOPLASMS; PAPILLOMA, INVERTED; PARANASAL SINUSES;

EID: 79953242970     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3566     Document Type: Article

References (32)

1. Phillips PP, Gustafson RO, and Facer GW. The clinical behavior of inverting papilloma of the nose and paranasal sinuses: Report of 112 cases and review of the literature. Laryngoscope 100:463-469, 1990. (Pubitemid 20152359)
2. Myers EN, Fernau JL, Johnson JT, et al. Management of inverted papilloma. Laryngoscope 100:481-490, 1990. (Pubitemid 20152363)
3. Lawson W, Ho BT, Shaari CM, et al. Inverted papilloma: A report of 112 cases. Laryngoscope 105:282-288, 1995.
4. Roh HJ, Procop GW, Batra PS, et al. Inflammation and the pathogenesis of inverted papilloma. Am J Rhinol 18:65-74, 2004. (Pubitemid 38714305)
5. Orlandi RR, Rubin A, Terrell JE, et al. Sinus inflammation associated with contralateral inverted papilloma. Am J Rhinol 16:91-95, 2002. (Pubitemid 34520825)
6. Harris CC, and Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327, 1993. (Pubitemid 23317333)
7. Hartwell LH, and Kastan MB. Cell cycle control and cancer. Science 266:1821-1828, 1994.
8. Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993. (Pubitemid 23346377)
9. Rocco JW, and Sidransky D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264:42-55, 2001.
10. van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156-1158, 1994. (Pubitemid 24108049)
11. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: Implications for field cancerization. Cancer Res 56:2488-2492, 1996. (Pubitemid 26170679)
12. Papadimitrakopoulou V, Izzo J, Lippman SM, et al. Frequent inactivation of p16INK4a in oral premalignant lesions. Oncogene 14:1799-1803, 1997. (Pubitemid 27207680)
13. Lefkimmiatis K, Caratozzolo MF, Merlo P, et al. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Cancer Res 69:8563-8571, 2009.
14. Lo Muzio L, Santarelli A, Caltabiano R, et al. p63 overexpression associates with poor prognosis in head and neck squamous cell carcinoma. Hum Pathol 36:187-194, 2005. (Pubitemid 40313576)
15. Ramer N, Wu H, Sabo E, et al. Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis. Cancer 116:77-83, 2010.
16. Edge SB, and Compton CC. The American Joint Committee on Cancer: The 7th ed of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471-1474, 2010.
17. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260:502-508, 2003. (Pubitemid 37363578)
18. Franzmann MB, Buchwald C, Jacobsen GK, et al. Expression of p53 in normal nasal mucosa and in sinonasal papillomas with and without associated carcinoma and the relation to human papillomavirus (HPV). Cancer Lett 128:161-164, 1998. (Pubitemid 28318730)
19. Fang SY, Yan JJ, and Ohyama M. Immunohistochemistry of p53 in sinonasal inverted papilloma and associated squamous cell carcinoma. Am J Rhinol 12:119-124, 1998. (Pubitemid 128752226)
20. Altavilla G, Staffieri A, Busatto G, et al. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol 129:1242-1249, 2009.
21. Katori H, Nozawat A, and Tsukuda M. Relationship between p21 and p53 expression, human papilloma virus infection and malignant transformation in sinonasal-inverted papilloma. Clin Oncol (R Coll Radiol) 18:300-305, 2006.
22. Fan GK, Imanaka M, Yang B, et al. Characteristics of nasal inverted papilloma and its malignant transformation: A study of cell proliferation and programmed cell death. Am J Rhinol 20:360-363, 2006. (Pubitemid 44083422)
23. Robinson S, Tan LW, James C, et al. Do nasal polyps and inverted papilloma have similar disorders in cell cycle regulation? Am J Rhinol 20:637-640, 2006.
24. Yang W, Qi Q, Zhang H, et al. p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer. Ann Surg Oncol 17:1453-1458, 2010.
25. Nemes JA, Nemes Z, and Marton IJ. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. J Oral Pathol Med 34:274-279, 2005. (Pubitemid 40524967)
26. Xie X, Clausen OP, and Boysen M. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas. Arch Otolaryngol Head Neck Surg 128:897-902, 2002. (Pubitemid 34856258)
27. Ai L, Stephenson KK, Ling W, et al. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: A promoter methylation and protein expression study in 100 cases. Mod Pathol 16:944-950, 2003. (Pubitemid 37152025)
28. Okami K, Reed AL, Cairns P, et al. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene 18:3541-3545, 1999. (Pubitemid 29317349)
29. El-Naggar AK, Lai S, Clayman GL, et al. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: Biological and clinical implications. Hum Pathol 30: 1013-1018, 1999.
30. Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 38:235-243, 2002. (Pubitemid 34442544)
31. Weinberger PM, Yu Z, Haffty BG, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res 10:5684-5691, 2004. (Pubitemid 39180943)
32. Foschini MP, Gaiba A, Cocchi R, et al. Pattern of p63 expression in squamous cell carcinoma of the oral cavity. Virchows Arch 444: 332-339, 2004. (Pubitemid 38553637)